Dr. Yanhong Duo research focuses on advancing nanomedicine with a keen emphasis on developing innovative strategies for cancer treatment and immunotherapy. Their work delves into the development of novel carrier-free nanodrugs, supramolecular nano-twin-drugs, and targeted drug delivery systems using aggregation-induced emission (AIE) luminogens. They also explore the intersection of nanotechnology and immunotherapy, aiming to enhance the efficacy of cancer treatments while minimizing side effects. Through their investigations, Dr. Duo aims to illuminate new pathways for combating cancer, offering hope for improved patient outcomes. š§¬š¬ Their multidisciplinary approach integrates nanotechnology, immunology, and oncology, paving the way for transformative advancements in cancer therapeutics.